계명대학교 의학도서관 Repository

딸기코종형 주사로 오인된 원발 피부 소포중심 림프종 1예

Metadata Downloads
Author(s)
Young-Wook RyooSung-Ae KimWon-Oh KimJin-Woong Jung
Keimyung Author(s)
Kim, Sung AeRyoo, Young Wook
Department
Dept. of Dermatology (피부과학)
Journal Title
대한피부과학회지
Issued Date
2019
Volume
57
Issue
2
Keyword
Phymatous rosaceaPrimary cutaneous B-cell lymphomaPrimary cutaneous follicle center lymphoma
Abstract
PCFCL is a subtype of primary cutaneous B-cell lymphoma (PCBCL), which is defined as a neoplasm of the centrocytes and centroblasts with or without the formation of follicles. It is rare in Asians and shows considerable variability in terms of clinical presentation and histological features, which makes it difficult to diagnose. A 77-year-old man visited our clinic with a 2-month history of erythematous telangiectatic patches and plaques on the face. Under the suspicion of phymatous rosacea, he received two pulsed dye-laser treatments at a local medical center and four pulsed dye-laser treatments at our outpatient clinic, but showed no improvement. Skin biopsy and immunohistochemical findings were compatible with PCFCL. Computed tomography (CT), positron emission tomography–computed tomography (PET-CT) and bone marrow biopsy revealed no evidence of extracutaneous involvement. Skin lesions improved after four cycles of chemotherapy with cyclophosphamide, vincristine, and prednisolone. Herein, we report an educational case of PCFCL misdiagnosed as phymatous rosacea.
Alternative Title
A Case of Primary Cutaneous Follicle Center Lymphoma (PCFCL) Misdiagnosed as Phymatous Rosacea
Keimyung Author(s)(Kor)
김성애
류영욱
Publisher
School of Medicine (의과대학)
Citation
Young-Wook Ryoo et al. (2019). 딸기코종형 주사로 오인된 원발 피부 소포중심 림프종 1예. 대한피부과학회지, 57(2), 84–88.
Type
Article
ISSN
0494-4739
Source
https://koreamed.org/article/0048KJD/2019.57.2.84
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/42144
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Dermatology (피부과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.